Abstract | OBJECTIVE: METHODS: Purified topo I or topo I released from apoptotic cells was tested for surface binding to a number of human cell types by cell-based enzyme-linked immunosorbent assay, flow cytometry, and indirect immunofluorescence. Antibodies purified from SSc patient and normal control sera were used to detect topo I binding. The consequences of topo I and anti- topo I binding to fibroblasts were assessed by coculture with THP-1 monocytes. RESULTS: The autoantigen topo I itself was found to bind specifically to fibroblasts in a dose-dependent and saturable manner, where it was recognized by anti- topo I from SSc patients. The binding of anti- topo I subsequently stimulated adhesion and activation of cocultured monocytes. Topo I released from apoptotic endothelial cells was also found to bind specifically to fibroblasts. CONCLUSION: The findings of this study thus confirm and extend the findings of our previous study by showing that topo I binding to fibroblast surfaces is both necessary and sufficient for anti- topo I binding. Second, topo I-anti- topo I complex binding can then trigger the adhesion and activation of monocytes, thus providing a plausible model for the amplification of the fibrogenic cascade in anti- topo I-positive SSc patients.
|
Authors | Jill Hénault, Geneviève Robitaille, Jean-Luc Senécal, Yves Raymond |
Journal | Arthritis and rheumatism
(Arthritis Rheum)
Vol. 54
Issue 3
Pg. 963-73
(Mar 2006)
ISSN: 0004-3591 [Print] United States |
PMID | 16508979
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Autoantibodies
- DNA Topoisomerases, Type I
|
Topics |
- Apoptosis
- Autoantibodies
(immunology)
- Cell Adhesion
(immunology)
- Cells, Cultured
- DNA Topoisomerases, Type I
(immunology)
- Electrophoresis
- Enzyme-Linked Immunosorbent Assay
- Fibroblasts
(immunology)
- Flow Cytometry
- Fluorescent Antibody Technique
- Humans
- Immunoblotting
- Microscopy, Confocal
- Monocytes
(immunology)
- Scleroderma, Systemic
(immunology)
|